C.PedersenL.BorghammerP.et al
Protocol 1: Conservative sub-therapeutic approach Goal: Target inflammation with minimal metabolic impact Starting dose: 0.5 to 1.0 mg tirzepatide weekly Escalation: Increase by 0.25 to 0.5 mg every 4 to 6 weeks based on inflammatory marker response Target maintenance: The lowest dose that produces measurable CRP/IL-6 reduction Monitoring schedule: Baseline: hsCRP, IL-6, complete metabolic panel, body weight Week 4: hsCRP, symptom assessment Week 8: hsCRP, IL-6, body weight Every 8 weeks thereafter: full inflammatory panel Duration: Minimum 12 weeks to assess response, with ongoing reassessment Best for: Normal-weight individuals with elevated inflammatory markers, autoimmune patients who cannot afford weight loss This protocol uses the compounded tirzepatide dosage calculator approach since standard vials are not designed for sub-2.5 mg dosing

In addition to this effect, GLP activation slows down how fast food leaves the stomach and reduces your appetite, which can quiet food noise, ultimately leading to weight loss
Thank You only ordered last night and its already arrived the day after very happy.ive used this every year for 6 years and I love it.gives you a lovely all over tan and Ive never been so brown Been using this for over a year now its fab
Knight 2
Front Physiol 11:578966